Addison's Disease in Dogs: Clinical Diagnosis, Treatment & Management

Quick Q&A

Question: What is the most common cause of Addison's disease in dogs? Answer: The most common cause is immune-mediated destruction of the adrenal cortex, leading to primary hypoadrenocorticism. This results in deficiencies of both mineralocorticoids (aldosterone) and glucocorticoids (cortisol), which are essential for electrolyte balance and stress response.

Question: How is Addison's disease definitively diagnosed in dogs? Answer: The gold standard diagnostic test is the ACTH stimulation test, which measures cortisol levels before and after administration of synthetic ACTH (cosyntropin). A blunted or absent post-ACTH cortisol response confirms the diagnosis. Baseline electrolyte abnormalities (low sodium, high potassium) provide strong supportive evidence.

Question: Can a dog with Addison's disease live a normal life? Answer: Yes, with appropriate lifelong medication and monitoring, most dogs with Addison's disease can live a normal, high-quality life. Treatment involves replacing the deficient hormones, typically with injectable desoxycorticosterone pivalate (DOCP) or oral fludrocortisone, plus oral glucocorticoid supplementation (prednisolone) as needed.

Introduction

Addison's disease, formally known as hypoadrenocorticism, is a relatively uncommon but potentially life-threatening endocrine disorder in dogs. It results from the inadequate production of corticosteroid hormones by the adrenal glands. While the condition can be challenging to diagnose due to its vague and waxing-waning clinical signs, it is one of the most rewarding diseases to treat in veterinary medicine, as affected dogs often return to a normal quality of life with appropriate therapy. This master reference guide provides a comprehensive, evidence-based overview of Addison's disease in dogs, covering pathophysiology, clinical presentation, diagnostic approach, emergency management, and long-term treatment protocols. It is designed for both veterinary professionals and dedicated pet owners seeking a deep understanding of this condition.

Pathophysiology of Hypoadrenocorticism

The Adrenal Gland and Its Hormones

The adrenal glands, located craniomedial to each kidney, consist of two functionally distinct regions: the outer cortex and the inner medulla. The adrenal cortex is further divided into three zones, each responsible for producing specific classes of steroid hormones:

• Zona Glomerulosa: Produces mineralocorticoids, primarily aldosterone. Aldosterone is the primary regulator of sodium, potassium, and water balance. It acts on the renal distal tubules and collecting ducts to promote sodium reabsorption and potassium and hydrogen ion excretion.
• Zona Fasciculata: Produces glucocorticoids, primarily cortisol. Cortisol has a wide range of effects, including regulation of carbohydrate, protein, and fat metabolism; suppression of the immune response; and maintenance of vascular tone and blood pressure. It is also the body's primary "stress hormone," essential for coping with physical and emotional stressors.
• Zona Reticularis: Produces adrenal androgens (sex hormones), which are of lesser clinical significance in dogs.

Primary Hypoadrenocorticism (Typical Addison's Disease)

Primary hypoadrenocorticism accounts for over 90% of naturally occurring cases in dogs [29]. It is characterized by the destruction of all three zones of the adrenal cortex, leading to a combined deficiency of both mineralocorticoids (aldosterone) and glucocorticoids (cortisol).

Etiology: The vast majority of cases are believed to be immune-mediated, where the dog's own immune system attacks the adrenal cortical cells. This is supported by the identification of circulating anti-adrenal antibodies in some affected dogs and the strong breed predispositions observed [4]. A recent genome-wide association study in Nova Scotia Duck Tolling Retrievers identified a variant in the RESF1 gene that is significantly associated with Addison's disease and multiple autoimmune syndrome in this breed [4]. Other, less common causes include:

• Adrenal hemorrhage: Bilateral adrenal hemorrhage can acutely destroy adrenal tissue, presenting as an Addisonian crisis. A recent case report described a vena caval hematoma secondary to adrenal hemorrhage from an Addisonian crisis in a dog [2].
• Adrenal neoplasia: Bilateral adrenal tumors (e.g., lymphoma, metastatic carcinoma) can rarely destroy sufficient adrenal tissue to cause clinical hypoadrenocorticism [40].
• Granulomatous disease: Fungal infections (e.g., histoplasmosis) or other infiltrative diseases can destroy the adrenal glands.
• Iatrogenic: Sudden withdrawal of exogenous glucocorticoids after long-term therapy can cause secondary hypoadrenocorticism (see below).
• Idiopathic necrosis: Acute adrenal necrosis, as reported in a young female cat, can also occur in dogs [19].

Consequences of Aldosterone Deficiency: The lack of aldosterone leads to an inability to conserve sodium and excrete potassium. This results in:

• Hyponatremia (low serum sodium)
• Hyperkalemia (high serum potassium)
• Hypochloremia
• Metabolic acidosis (due to impaired hydrogen ion excretion)
• Loss of renal concentrating ability (due to medullary solute washout)
• Hypovolemia and hypotension (due to sodium and water loss)

The classic electrolyte disturbance of a low Na:K ratio (sodium to potassium ratio) is a hallmark of typical Addison's disease. A ratio below 27:1 is highly suggestive, and a ratio below 24:1 is considered diagnostic in the appropriate clinical context. However, it is critical to note that the Na:K ratio is not pathognomonic; it can be seen in other conditions such as severe gastrointestinal disease, renal disease, and chylothorax.

Consequences of Cortisol Deficiency: The lack of cortisol leads to a wide range of clinical signs, including:

• Gastrointestinal signs: Anorexia, vomiting, diarrhea (sometimes hemorrhagic), and weight loss. Cortisol deficiency impairs the ability to maintain gastrointestinal mucosal integrity and regulate inflammation.
• Lethargy and weakness: Cortisol is essential for maintaining normal energy metabolism and vascular tone.
• Hypoglycemia: Cortisol deficiency impairs gluconeogenesis, leading to fasting hypoglycemia, which can cause weakness, collapse, and seizures.
• Inability to handle stress: Dogs with Addison's disease cannot mount a normal stress response, making them susceptible to Addisonian crises triggered by stressors such as boarding, surgery, or intercurrent illness.
• Relative polyuria and polydipsia: Due to loss of renal concentrating ability and sodium wasting.

Secondary Hypoadrenocorticism (Atypical Addison's Disease)

Secondary hypoadrenocorticism results from a deficiency of adrenocorticotropic hormone (ACTH) from the pituitary gland. Since ACTH primarily stimulates cortisol production from the zona fasciculata, and the zona glomerulosa (aldosterone production) is largely under the control of the renin-angiotensin-aldosterone system (RAAS), dogs with secondary hypoadrenocorticism typically have cortisol deficiency alone with normal electrolyte concentrations (eunatremia, eukalemia). This is often referred to as atypical hypoadrenocorticism [18, 22, 24].

Etiology: The most common cause is iatrogenic, resulting from the abrupt withdrawal of exogenous glucocorticoids (e.g., prednisolone, dexamethasone) after long-term therapy. This suppresses the pituitary's ability to produce ACTH. Other causes include:

• Pituitary neoplasia: A pituitary tumor (e.g., a non-functional adenoma or a craniopharyngioma) can destroy the corticotroph cells that produce ACTH. Conversely, an ACTH-producing pituitary adenoma can cause pituitary apoplexy (hemorrhage) leading to secondary hypoadrenocorticism [23].
• Pituitary trauma or inflammation
• Idiopathic: In some cases, the cause remains unknown.

Clinical Significance of Atypical Hypoadrenocorticism: Atypical hypoadrenocorticism is often more insidious and difficult to diagnose because the classic electrolyte abnormalities are absent. These dogs may present with vague, chronic gastrointestinal signs, lethargy, and weakness, often mimicking other diseases like inflammatory bowel disease (IBD) or chronic enteropathy. A recent study found that a significant proportion of dogs with signs of chronic gastrointestinal disease had eunatremic, eukalemic hypoadrenocorticism, and there is a risk of misdiagnosis if glucocorticoids have been administered previously [18]. Dogs with atypical disease are also at risk of developing electrolyte abnormalities later in life as the disease progresses to involve the zona glomerulosa [22].

Primary vs. Secondary vs. Atypical: A Summary

| Feature | Primary (Typical) | Secondary (Atypical) | | :-, | :-, | :-, | | Deficiency | Aldosterone + Cortisol | Cortisol only (initially) | | Serum Na+ | Decreased (Hyponatremia) | Normal (Eunatremia) | | Serum K+ | Increased (Hyperkalemia) | Normal (Eukalemia) | | Na:K Ratio | Decreased (<27:1) | Normal | | ACTH Stim Test | Blunted cortisol response | Blunted cortisol response | | Endogenous ACTH | High (due to loss of negative feedback) | Low to undetectable | | Renin Activity | High | Normal | | Common Cause | Immune-mediated destruction | Iatrogenic (steroid withdrawal) or pituitary disease |

Signalment and Breed Predispositions

While Addison's disease can affect any dog, certain breeds and demographics are overrepresented.

• Breed Predispositions: A strong genetic component is evident. Breeds at increased risk include:
  • Standard Poodle
  • Bearded Collie [37]
  • Nova Scotia Duck Tolling Retriever [4]
  • Portuguese Water Dog
  • Leonberger
  • Great Dane
  • West Highland White Terrier
  • Soft Coated Wheaten Terrier
  • Labrador Retriever
  • Rottweiler
• Age: Most dogs are diagnosed in young to middle adulthood (2 to 6 years of age). However, the condition can occur at any age.
• Sex: A female predisposition has been reported in some studies, though others show no sex predilection.

Clinical Presentation

The clinical signs of Addison's disease are notoriously vague, waxing and waning, and can mimic many other diseases. This often leads to a delayed diagnosis, with the condition being described as "the great pretender" or "the great imitator."

Chronic, Non-Specific Signs

Many dogs present with a history of intermittent or chronic signs that may go unnoticed or be attributed to other issues:

• Lethargy and depression: A general lack of energy and enthusiasm.
• Anorexia or decreased appetite: Picky eating or complete refusal of food.
• Weight loss: Due to poor nutrient absorption and catabolism.
• Vomiting and diarrhea: Often intermittent and non-specific. Some dogs may have melena or hematochezia.
• Polyuria and polydipsia (PU/PD): Increased thirst and urination, often mistaken for kidney disease or diabetes.
• Trembling or shaking: Can be mistaken for anxiety or pain.
• Weakness and exercise intolerance: The dog tires easily on walks or seems reluctant to move.

The Addisonian Crisis (Acute Presentation)

An Addisonian crisis is a life-threatening medical emergency. It occurs when the body's compensatory mechanisms fail, often triggered by a stressor such as infection, surgery, trauma, or a change in medication. The classic presentation is that of a hypovolemic, hyponatremic, hyperkalemic, and hypoglycemic shock.

• Collapse and profound weakness: The dog may be unable to stand (recumbent).
• Bradycardia: Hyperkalemia has a direct cardiotoxic effect, causing decreased heart rate and potentially life-threatening arrhythmias. A transient third-degree atrioventricular block has been reported in a dog with Addisonian crisis [12].
• Weak, thready pulses: Due to hypovolemia and hypotension.
• Prolonged capillary refill time (CRT): Indicative of poor peripheral perfusion.
• Hypothermia: Due to shock and inability to thermoregulate.
• Hypoglycemia: Can cause seizures, stupor, or coma. A case report described a dog with eunatremic, eukalemic hypoadrenocorticism presenting with asymmetric multifocal neurological signs due to severe hypoglycemia [10].
• Acute kidney injury (AKI): The severe hypovolemia and hypotension can mimic or cause AKI. A retrospective study found that Addisonian crisis can be misdiagnosed as acute kidney injury [8].
• Gastrointestinal hemorrhage: Hematemesis or melena may be present.

Atypical Presentation: Eunatremic, Eukalemic Hypoadrenocorticism

As discussed, dogs with atypical hypoadrenocorticism (cortisol deficiency only) present a diagnostic challenge. They often have a history of chronic, waxing-waning gastrointestinal signs (vomiting, diarrhea, anorexia) and lethargy, with completely normal serum electrolytes [18, 24]. These dogs are frequently misdiagnosed with inflammatory bowel disease, chronic enteropathy, or dietary indiscretion. The key is to consider hypoadrenocorticism in any dog with chronic GI signs, especially if they are young, of a predisposed breed, or have a history of waxing-waning illness.

Diagnostic Approach

The diagnosis of Addison's disease requires a high index of suspicion. It is a multi-step process involving signalment, history, physical examination, routine laboratory work, and specific endocrine testing.

Step 1: Suspicion Based on Routine Lab Work

The most common initial clue is the finding of hyponatremia and hyperkalemia on a routine serum biochemistry panel.

• Sodium (Na+): Decreased (< 140 mEq/L)
• Potassium (K+): Increased (> 5.5 mEq/L)
• Na:K Ratio: A ratio of < 27:1 is highly suspicious. A ratio of < 24:1 is considered diagnostic for hypoadrenocorticism in the right clinical context. However, it is not 100% specific. Conditions like severe trichuriasis (whipworm infection), chylothorax, renal disease, and severe GI disease can also cause a low Na:K ratio.
• Chloride (Cl-): Usually decreased in parallel with sodium.
• Calcium: Mild hypercalcemia can be seen in some dogs with Addison's disease due to hemoconcentration and altered calcium metabolism.
• Blood Urea Nitrogen (BUN) and Creatinine: Often elevated (prerenal azotemia) due to hypovolemia and decreased renal perfusion. This can mimic primary kidney disease [8].
• Glucose: May be low (hypoglycemia), especially in atypical cases.
• Albumin: Can be low due to gastrointestinal loss.
• Complete Blood Count (CBC): A stress leukogram (neutrophilia, lymphopenia, eosinopenia) is typically absent in Addison's disease, which is a key clue. Instead, a relative lymphocytosis and eosinophilia may be present due to the lack of cortisol.
• C-Reactive Protein (CRP): A recent study found that blood CRP concentrations are frequently abnormal in dogs with hypoadrenocorticism, though the clinical utility of this finding is still being explored [3].

Step 2: The Gold Standard: ACTH Stimulation Test

The ACTH stimulation test is the definitive diagnostic test for hypoadrenocorticism. It assesses the functional reserve of the adrenal cortex.

Protocol:

1. Collect a baseline blood sample for serum cortisol measurement.
2. Administer synthetic ACTH (cosyntropin) intravenously or intramuscularly.
   • Standard dose: 5 mcg/kg (maximum 250 mcg/dog) IV or IM.
   • Low-dose protocol: 1 mcg/kg IV is also used by some clinicians and may be more sensitive for detecting early disease.
3. Collect a post-ACTH blood sample for serum cortisol measurement at 60 minutes (IV) or 60-90 minutes (IM).

Interpretation:

• Normal Response: Post-ACTH cortisol > 5-6 mcg/dL (138-165 nmol/L), depending on the laboratory reference range.
• Hypoadrenocorticism: Post-ACTH cortisol < 2 mcg/dL (55 nmol/L) . A blunted or absent response confirms the diagnosis.
• Equivocal Response: Post-ACTH cortisol between 2-5 mcg/dL. This may indicate early or partial disease, and the test should be repeated in 1-3 months.

Important Considerations:

• Previous Glucocorticoid Administration: Exogenous glucocorticoids (especially prednisolone, methylprednisolone, and dexamethasone) can suppress the ACTH stimulation test results, leading to a false-positive diagnosis of hypoadrenocorticism. A recent study highlighted the risk of misdiagnosis after prior glucocorticoid administration [18]. Ideally, the test should be performed before starting steroids. If steroids have been given, a washout period may be necessary, but this must be weighed against the patient's clinical stability.
• Trilostane Therapy: Dogs being treated for Cushing's disease (hyperadrenocorticism) should not be tested for Addison's disease while on trilostane, as trilostane is designed to suppress cortisol production.
• Endogenous ACTH Measurement: Measuring baseline endogenous ACTH can help differentiate primary from secondary disease. In primary disease, endogenous ACTH is high (due to loss of cortisol negative feedback). In secondary disease, it is low to undetectable. This is not always necessary for management but can be helpful in complex cases.

Step 3: Ancillary Diagnostic Tests

• Electrocardiogram (ECG): In hyperkalemic patients, ECG changes include:
  • Peaked T waves (tenting)
  • Widened QRS complexes
  • Decreased R wave amplitude
  • Prolonged P-R interval
  • Atrial standstill (loss of P waves)
  • Ventricular fibrillation or asystole (in severe cases) [12]
• Abdominal Ultrasound: May show small, hypoechoic adrenal glands (< 3-4 mm in diameter). However, normal-sized adrenals do not rule out the disease. Ultrasound is also useful to rule out other causes of GI signs or to identify adrenal masses [24, 40].
• Urine Cortisol:Creatinine Ratio (UCCR): While primarily used to screen for Cushing's disease, a very low UCCR can support a diagnosis of hypoadrenocorticism [31].
• Machine Learning Models: Recent advances have explored the use of machine learning tools to screen for hypoadrenocorticism using signalment and routine laboratory results. These models show promise for improving diagnostic accuracy and identifying cases that might otherwise be missed [5, 26].

Step 4: Differentiating Addison's Disease from Other Conditions

The differential diagnosis for the signs of Addison's disease is extensive. The following table highlights key differentiating features:

| Condition | Differentiating Features from Addison's Disease | | :-, | :-, | | Acute Kidney Injury (AKI) | AKI typically presents with hyperkalemia and azotemia, but sodium is usually normal or low-normal. Urine specific gravity is often isosthenuric (fixed). A history of nephrotoxin exposure or other renal disease is common. The ACTH stim test is normal. | | Chronic Kidney Disease (CKD) | CKD causes PU/PD, weight loss, and vomiting. Electrolytes can be variable. The ACTH stim test is normal. | | Severe Gastrointestinal Disease (e.g., Parvovirus, Hemorrhagic Gastroenteritis, Whipworms) | Can cause hyponatremia and hyperkalemia due to fluid and electrolyte losses. The ACTH stim test is normal. Fecal testing and GI-specific diagnostics are helpful. | | Diabetic Ketoacidosis (DKA) | Presents with hyperglycemia, glucosuria, and ketonuria. Electrolyte disturbances are common but typically include hypernatremia (due to water loss) and hypokalemia (due to urinary loss). | | Chylothorax | Can cause hyponatremia and hyperkalemia due to the composition of chyle. The ACTH stim test is normal. Thoracic imaging reveals pleural effusion. | | Hypoglycemia (from other causes) | Insulinoma, sepsis, or liver failure can cause hypoglycemia. The ACTH stim test is normal. | | Heartworm Disease (Caval Syndrome) | Can cause collapse, hypotension, and hemolysis. Electrolytes are usually normal. Heartworm testing and echocardiography are diagnostic. |

Emergency Management of the Addisonian Crisis

An Addisonian crisis is a life-threatening emergency requiring immediate and aggressive intervention. The goals of therapy are to correct hypovolemia, electrolyte imbalances, hypoglycemia, and acidosis, and to provide immediate hormone replacement.

Step 1: Stabilize the Airway, Breathing, and Circulation (ABCs)

• Intravenous (IV) Access: Place two large-bore IV catheters.
• IV Fluid Resuscitation: Administer a 0.9% Sodium Chloride (Saline) bolus. Lactated Ringer's Solution (LRS) or Normosol-R should be avoided as they contain potassium, which will worsen hyperkalemia.
  • Bolus dose: 10-20 mL/kg IV over 15-20 minutes. This can be repeated up to a total of 60-90 mL/kg in the first hour, titrated to effect (improved heart rate, pulse quality, blood pressure, and mentation).
• Correct Hypoglycemia: If blood glucose is low (< 60 mg/dL), administer a 0.5-1.0 mL/kg bolus of 50% Dextrose diluted 1:2 or 1:4 with saline to avoid phlebitis, or a constant rate infusion (CRI) of 2.5-5% dextrose in saline.
• Correct Hyperkalemia: In most cases, hyperkalemia will resolve with fluid resuscitation and the administration of mineralocorticoids. However, if life-threatening cardiac arrhythmias (e.g., atrial standstill, severe bradycardia) are present, specific interventions are needed:
  • Regular Insulin (0.25-0.5 U/kg IV) + Dextrose (2 g/U of insulin): Drives potassium into cells.
  • Calcium Gluconate (10% solution, 0.5-1.0 mL/kg IV over 10-20 minutes): Protects the heart from the cardiotoxic effects of hyperkalemia. Monitor ECG during administration.
  • Sodium Bicarbonate (1-2 mEq/kg IV over 15-30 minutes): Shifts potassium into cells in exchange for hydrogen ions. Use with caution, especially if ventilation is compromised.

Step 2: Immediate Hormone Replacement

• Glucocorticoid Replacement: Administer a rapid-acting, injectable glucocorticoid. Dexamethasone Sodium Phosphate (0.5-2.0 mg/kg IV) is preferred because it does not interfere with the ACTH stimulation test if the test has not been performed yet. If the ACTH stim test has already been done, Prednisolone Sodium Succinate (5-10 mg/kg IV) can be used.
• Mineralocorticoid Replacement: For long-term management, a mineralocorticoid is needed. In the acute crisis, the mineralocorticoid effect of high-dose glucocorticoids (especially prednisolone) and fluid resuscitation is often sufficient for the first 24 hours. However, the first dose of a long-acting mineralocorticoid can be given once the patient is stable.

Step 3: Monitoring and Supportive Care

• Continuous ECG monitoring for arrhythmias.
• Frequent blood pressure monitoring (Doppler or oscillometric).
• Serial blood work (electrolytes, glucose, BUN, creatinine) every 4-6 hours initially, then daily as the patient stabilizes.
• Monitor urine output to assess renal function.
• Treat underlying triggers (e.g., antibiotics for infection, antiemetics for vomiting).

Once the patient is hemodynamically stable, the focus shifts to long-term management.

Long-Term Treatment and Management

Lifelong therapy is required for dogs with Addison's disease. The goal is to replace the deficient hormones, allowing the dog to live a normal, healthy life. Treatment involves two main components: mineralocorticoid replacement and glucocorticoid replacement.

Mineralocorticoid Replacement

This is the cornerstone of therapy for dogs with primary (typical) hypoadrenocorticism. Two main options are available:

1. Desoxycorticosterone Pivalate (DOCP)

DOCP is a long-acting, injectable mineralocorticoid. It is considered the preferred treatment by many veterinary endocrinologists due to its convenience and consistent efficacy. It is available under the brand name Zycortal (in Europe, Australia, and other regions) and Percorten-V (in the United States).

• Mechanism of Action: DOCP is a synthetic mineralocorticoid that acts on the renal tubules to promote sodium reabsorption and potassium excretion. It has no significant glucocorticoid activity.
• Dosing Protocol:
  • Initial Loading Dose: 2.2 mg/kg (1.0 mg/lb) subcutaneously (SQ).
  • Recheck Electrolytes: Measure serum sodium and potassium concentrations 10-14 days after the injection.
  • Dose Adjustment: The goal is to normalize the Na:K ratio (ideally > 27:1) without causing hypernatremia or hypokalemia. The dose can be adjusted in 0.5-1.0 mg/kg increments based on the electrolyte results. Some dogs may require a lower dose (e.g., 1.5 mg/kg), and recent studies have explored the efficacy of low-dose DOCP protocols [34, 39].
  • Dosing Interval: The interval between injections is typically 21-30 days. The recheck electrolytes at 10-14 days help determine the optimal interval. If electrolytes are normal at day 14 but become abnormal by day 28, the interval should be shortened to 25 days. If they are normal at day 25, the interval can be extended to 30 days.
• Monitoring: Electrolytes should be rechecked at each injection for the first 2-3 doses, then every 3-6 months once stable. A recent study investigated the pharmacokinetics and pharmacodynamics of DOCP in dogs with hypoadrenocorticism, providing valuable data for optimizing dosing protocols [6, 11].
• Advantages: Once monthly injection, excellent owner compliance, consistent mineralocorticoid effect.
• Disadvantages: Requires veterinary administration (injection), more expensive upfront cost than fludrocortisone.

2. Fludrocortisone Acetate (Florinef)

Fludrocortisone is an oral mineralocorticoid with some glucocorticoid activity. It is a good alternative for owners who prefer to administer oral medication.

• Mechanism of Action: Similar to DOCP, it promotes sodium retention and potassium excretion.
• Dosing Protocol:
  • Starting Dose: 0.01-0.02 mg/kg (0.005-0.01 mg/lb) orally once daily, divided into two doses (every 12 hours).
  • Dose Adjustment: The dose is titrated based on electrolyte monitoring. Most dogs require a total daily dose of 0.02-0.04 mg/kg. The dose is increased or decreased in 0.05-0.1 mg increments per day.
• Monitoring: Electrolytes should be checked 7-14 days after any dose change, then every 3-6 months once stable.
• Advantages: Oral administration, owner can dose at home, relatively inexpensive.
• Disadvantages: Requires twice-daily dosing, dose adjustments are more frequent, and it has some glucocorticoid activity which can complicate stress dosing.

Glucocorticoid Replacement

Dogs with primary hypoadrenocorticism also require glucocorticoid replacement. The mineralocorticoid (DOCP or fludrocortisone) does not provide sufficient glucocorticoid activity.

• Standard Replacement: Prednisolone (or prednisone) is the most commonly used glucocorticoid.
  • Starting Dose: 0.1-0.2 mg/kg (0.05-0.1 mg/lb) orally once daily.
  • Goal: The lowest dose that keeps the dog free of clinical signs (lethargy, anorexia, vomiting). Many dogs can be maintained on a very low dose (e.g., 0.05-0.1 mg/kg every other day) or even weaned off completely in some cases, though this is controversial. The goal is to avoid the side effects of chronic glucocorticoid therapy (e.g., PU/PD, polyphagia, muscle wasting, immunosuppression).
• Stress Dosing: This is a critical concept for owners to understand. When a dog with Addison's disease experiences a stressor (e.g., boarding, travel, surgery, illness, injury), their body cannot produce the extra cortisol needed to cope. Therefore, glucocorticoid doses must be increased during these times.
  • Mild Stress (e.g., car ride, grooming, mild illness): Give 2-3 times the maintenance dose of prednisolone for 1-2 days.
  • Moderate Stress (e.g., boarding, elective surgery, moderate illness): Give 3-5 times the maintenance dose for 2-3 days.
  • Severe Stress (e.g., major surgery, trauma, severe illness, Addisonian crisis): Give injectable dexamethasone or prednisolone sodium succinate at crisis doses (see above) and provide IV fluids.
  • Injectable Glucocorticoid for Home Use: Veterinarians may prescribe an injectable glucocorticoid (e.g., dexamethasone) for owners to keep on hand for emergencies, especially for dogs living in remote areas or with a history of severe crises.

Monitoring and Follow-Up

• Electrolyte Monitoring: This is the single most important monitoring tool. For dogs on DOCP, electrolytes are checked 10-14 days after each injection for the first few doses, then every 3-6 months. For dogs on fludrocortisone, electrolytes are checked 7-14 days after a dose change, then every 3-6 months.
• Clinical Signs: Owners should be educated to monitor for signs of over- or under-replacement.
  • Under-replacement (Addisonian signs): Lethargy, weakness, anorexia, vomiting, diarrhea, trembling, PU/PD.
  • Over-replacement (Cushingoid signs): PU/PD, polyphagia, muscle wasting, panting, pot-bellied appearance, alopecia. This is more common with excessive glucocorticoid use.
• Long-Term Health: Dogs with Addison's disease should have regular wellness exams, including blood pressure checks and urinalysis. There is evidence that long-term mineralocorticoid therapy can affect renal function, with one study showing changes in symmetric dimethylarginine (SDMA) and creatinine levels [35]. Another study evaluated longitudinal thyroid function in dogs with hypoadrenocorticism, finding that some dogs may develop concurrent autoimmune thyroiditis [15].
• Cardiac Function: A study identified ventricular systolic dysfunction in dogs diagnosed with hypoadrenocorticism, suggesting that cardiac monitoring may be warranted in some cases [28].

Prognosis

The prognosis for dogs with Addison's disease is excellent with appropriate diagnosis and lifelong management. Once stabilized on therapy, most dogs return to a normal, active life with a normal life expectancy. The key to a good prognosis is owner education and compliance. Owners must understand the importance of:

• Consistent medication administration.
• Regular veterinary monitoring.
• Stress dosing protocols.
• Recognizing the early signs of an impending crisis.

The most significant risk factor for a poor outcome is a delayed or missed diagnosis, particularly during an Addisonian crisis. With prompt and aggressive emergency care, even dogs in severe crisis have a good chance of recovery.

Prevention and Risk Factors

There is no known way to prevent immune-mediated Addison's disease. However, awareness of breed predispositions can lead to earlier screening. For dogs on long-term glucocorticoid therapy (e.g., for allergies or immune-mediated disease), the risk of iatrogenic hypoadrenocorticism can be minimized by:

• Tapering glucocorticoids slowly over weeks to months.
• Using the lowest effective dose for the shortest duration possible.
• Considering alternative therapies (e.g., cyclosporine, oclacitinib) for chronic conditions.

A case-control survey study investigated environmental risk factors for primary hypoadrenocorticism in dogs, but no strong modifiable risk factors have been identified to date [20].

Special Considerations

Concurrent Autoimmune Disease

Addison's disease is often part of a polyglandular autoimmune syndrome, where the immune system attacks multiple endocrine organs. Affected dogs may also develop:

• Hypothyroidism: The most common concurrent endocrinopathy. Routine thyroid screening is recommended [15].
• Diabetes Mellitus
• Hypoparathyroidism
• Chronic Inflammatory Bowel Disease (IBD)
• Immune-mediated Polyarthritis
• Glomerulonephritis

Pseudo-Addisonian Crisis

Certain conditions can mimic the electrolyte disturbances of an Addisonian crisis. A case report described a "pseudo-Addisonian crisis" with hyponatremia and hyperkalemia in a late pregnant bitch [1]. This highlights the importance of performing an ACTH stimulation test to confirm the diagnosis before committing to lifelong therapy.

Regional and Geographic Considerations

• North America: DOCP (Percorten-V) and fludrocortisone are widely available. The ACTH stimulation test is the standard of care.
• Europe: Zycortal (DOCP) is the preferred mineralocorticoid. The ACTH stimulation test is also standard.
• Australia: Zycortal is available. Veterinarians should be aware of the potential for tick paralysis (from Ixodes holocyclus) to cause weakness and collapse, which can mimic an Addisonian crisis.
• Tick-borne diseases: In endemic areas (e.g., Ehrlichiosis, Anaplasmosis), these infections can cause similar clinical signs and should be ruled out.

Owner FAQs

Q: How long does a dog with Addison's disease live? A: With proper treatment and monitoring, most dogs with Addison's disease live a normal lifespan. The disease itself does not shorten life expectancy if well-managed.

**Q: Can my dog with